ketanserin
Megjelenés
| Clinical data | |
|---|---|
| Trade names | Sufrexal, Serefrex |
| Other names | R-41468; R41468; R-41,468; KJK-945; R-49945; R49945 |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 50% |
| Protein binding | 95% (mainly albumin |
| Metabolism | Extensive |
| Metabolites | • Ketanserin-ol |
| Elimination half-life | 10–29 hours |
| Excretion | Urine; 2% unchanged |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C22H22FN3O3 |
| Molar mass | 395.434403163 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Főnév
ketanserin (tsz. ketanserins)
- ketanserin - Szótár.net (en-hu)
- ketanserin - Sztaki (en-hu)
- ketanserin - Merriam–Webster
- ketanserin - Cambridge
- ketanserin - WordNet
- ketanserin - Яндекс (en-ru)
- ketanserin - Google (en-hu)
- ketanserin - Wikidata
- ketanserin - Wikipédia (angol)